Muropeptide modification-amidation of peptidoglycan D-glutamate does not affect the proinflammatory activity of Staphylococcus aureus

Infection and Immunity

Volumn 75, Issue 4, 2007, Pages 2084-2087

  Kraus, Dirk ^a   Kalbacher, Hubert ^a   Buschmann, Julia ^a   Berger Bächi, Brigitte ^b   Götz, Friedrich ^a   Peschel, Andreas ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXTRO GLUTAMIC ACID; MURAMYL DIPEPTIDE; MUROPEPTIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE; PEPTIDOGLYCAN; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMIDATION; ARTICLE; BACTERIAL STRAIN; BACTERIUM MUTANT; CYTOKINE PRODUCTION; INFLAMMATION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN MODIFICATION; STAPHYLOCOCCUS AUREUS; WILD TYPE;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; CYTOKINES; GENE DELETION; GLUTAMIC ACID; HUMANS; LEUKOCYTES, MONONUCLEAR; PEPTIDOGLYCAN; STAPHYLOCOCCUS AUREUS;

EID: 34147110318     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01576-06     Document Type: Article

References (29)

1. Baechle, D., A. Cansier, R. Fischer, J. Brandenburg, T. Burster, C. Driessen, and H. Kalbacher. 2005. Biotinylated fluorescent peptide substrates for the sensitive and specific determination of cathepsin D activity. J. Pept. Sci. 11:166-174.
2. Barlos, K., O. Chatzl, D. Gatos, and G. Stavropoulos. 1991. 2-Chlorotrityl chloride resin. Studies on anchoring of Fmoc-amino acids and peptide cleavage. Int. J. Pept. Protein Res. 37:513-520.
3. Bera, A., S. Herbert, A. Jakob, W. Vollmer, and F. Götz. 2005. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol. Microbiol. 55:778-787.
4. Berger-Bächi, B., A. Strassle, J. E. Gustafson, and F. H. Kayser. 1992. Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 36:1367-1373.
5. Boneca, I. G. 2005. The role of peptidoglycan in pathogenesis. Curr. Opin. Microbiol. 8:46-53.
6. Bubeck Wardenburg, J., W. A. Williams, and D. Missiakas. 2006. Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins. Proc. Natl. Acad. Sci. USA 103:13831-13836.
7. Chamaillard, M., M. Hashimoto, Y. Horie, J. Masumoto, S. Qiu, L. Saab, Y. Ogura, A. Kawasaki, K. Fukase, S. Kusumoto, M. A. Valvano, S. J. Foster, T. W. Mak, G. Nunez, and N. Inohara. 2003. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4:702-707.
8. Cui, L., H. Murakami, K. Kuwahara-Arai, H. Hanaki, and K. Hiramatsu. 2000. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob. Agents Chemother. 44:2276-2285.
9. Dürr, M. C., S. A. Kristian, M. Otto, G. Matteoli, P. S. Margolis, J. Trias, K. P. Van Kessel, J. A. Van Strijp, E. Bohn, R. Landmann, and A. Peschel. 2006. Neutrophil chemotaxis by pathogen-associated molecular patterns - formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus. Cell Microbiol. 8:207-217.
10. Dziarski, R., and D. Gupta. 2005. Staphylococcus aureus peptidoglycan is a Toll-like receptor 2 activator: a reevaluation. Infect. Immun. 73:5212-5216.
11. Foster, T. J. 2004. The Staphylococcus aureus "superbug." J. Clin. Investig. 114:1693-1696.
12. Foster, T. J., and M. Hook. 1998. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 6:484-488.
13. Fournier, B., and D. J. Philpott. 2005. Recognition of Staphylococcus aureus by the innate immune system. Clin. Microbiol. Rev. 18:521-540.
14. Girardin, S. E., I. G. Boneca, L. A. Carneiro, A. Antignac, M. Jehanno, J. Viala, K. Tedin, M. K. Taha, A. Labigne, U. Zahringer, A. J. Coyle, P. S. DiStefano, J. Bertin, P. J. Sansonetti, and D. J. Philpott. 2003. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:1584-1587.
15. Girardin, S. E., L. H. Travassos, M. Herve, D. Blanot, I. G. Boneca, D. J. Philpott, P. J. Sansonetti, and D. Mengin-Lecreulx. 2003. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 278:41702-41708.
16. Götz, F., T. Bannerman, and K.-H. Schleifer. 2006. The genera Staphylococcus and Macrococcus, p. 45-75. In M. Dworkin (ed.), The prokaryotes: an evolving electronic resource for the microbiological community. Springer Verlag, New York, NY.
17. Gustafson, J., A. Strassle, H. Hachler, F. H. Kayser, and B. Berger-Bachi. 1994. The femC locus of Staphylococcus aureus required for methicillin resistance includes the glutamine synthetase operon. J. Bacteriol. 176:1460-1467.
18. Inohara, N., M. Chamaillard, C. McDonald, and G. Nunez. 2005. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74:355-383.
19. Inohara, N., Y. Ogura, A. Fontalba, O. Gutierrez, F. Pons, J. Crespo, K. Fukase, S. Inamura, S. Kusumoto, M. Hashimoto, S. J. Foster, A. P. Moran, J. L. Fernandez-Luna, and G. Nunez. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278:5509-5512.
20. Komatsuzawa, H., K. Ohta, H. Labischinski, M. Sugai, and H. Suginaka. 1999. Characterization of fmtA, a gene that modulates the expression of methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 43:2121-2125.
21. Kraus, D., and A. Peschel. 2006. Molecular mechanisms of bacterial resistance to antimicrobial peptides. Curr. Top. Microbiol. Immunol. 306:231-250.
22. Peschel, A., and H. G. Sahl. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4:529-536.
23. Siewert, G., and J. L. Strominger. 1968. Biosynthesis of the peptidoglycan of bacterial cell walls. XI. Formation of the isoglutamine amide group in the cell walls of Staphylococcus aureus. J. Biol. Chem. 243:783-790.
24. Sinha, R. K., and F. C. Neuhaus. 1991. Biosynthesis of peptidoglycan in Gaffkya homari: on the target(s) of benzylpenicillin. Antimicrob. Agents Chemother. 35:1753-1759.
25. Stoll, H., J. Dengjel, C. Nerz, and F. Götz. 2005. Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect. Immun. 73:2411-2423.
26. Strandén, A. M., M. Roos, and B. Berger-Bachi. 1996. Glutamine synthetase and heteroresistance in methicillin-resistant Staphylococcus aureus. Microb. Drug Resist. 2:201-207.
27. Travassos, L. H., S. E. Girardin, D. J. Philpott, D. Blanot, M. A. Nahori, C. Werts, and I. G. Boneca. 2004. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 5:1000-1006.
28. Weidenmaier, C., J. F. Kokai-Kun, S. A. Kristian, T. Chanturyia, H. Kalbacher, M. Gross, G. Nicholson, B. Neumeister, J. J. Mond, and A. Peschel. 2004. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat. Med. 10:243-245.
29. Wilkinson, B. J. 1997. Biology, p. 1-38. In K. B. Crossley and G. L. Archer (ed.), The staphylococci in human disease. Churchill Livingstone, New York, NY.